The North America Human Milk Oligosaccharides Market would witness market growth of 23.0% CAGR during the forecast period (2023-2030).
Human milk oligosaccharide (HMO) is a highly concentrated unconjugated glycan with a complex structure present in human milk. With negligible digestion in the gastrointestinal tract, HMOs reach the colon unaltered, where they exert their influence on the microbiota. As HMOs are beneficial for immunity, several new techniques are being developed by key players in the market, such as isolating HMO from cow milk, employing costly techniques, or utilizing microbes to produce them. market products are expensive, as a large amount of human milk is synthesized to make a small amount of HMO. As a result, techniques for synthesis and extraction are improving with continuous research and development activities.
The functional benefits of these products have created a massive demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements. One of the significant factors and market trends that boosts the its growth is the availability of new technologies like enzymatic trans-glycosylation, which is used for artificially synthesizing the HMOs.
According to Statistics Canada, in 2020, fortified/functional (FF) foods and beverages represented the highest sales value in the US within the health and wellness (H&W) foods and beverage sector at US$67.9 billion. The increasing emphasis on wellness and health has led consumers in the US to seek functional foods and beverages that go beyond essential nutrition. HMOs, known for their potential prebiotic and immune-modulating properties, align with these health-focused preferences. The food and beverage industry in the US is known for its innovation in product formulations. The above aspects will expand the market growth across the region in the upcoming years.
The US market dominated the North America Human Milk Oligosaccharides Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $151,168.8 Thousand by 2030. The Canada market is experiencing a CAGR of 25.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 24.7% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Functional Food & Beverages, Food Supplements, and Others (Clinical Nutrition & Pharmaceuticals). Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL, and 6'SL. Based on Concentration, the market is segmented into Neutral, and Acidic. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Human Milk Oligosaccharides Market is Predict to reach $1 Billion by 2030, at a CAGR of 23.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A).
Scope of the Study
Market Segments Covered in the Report:
By Application
- Infant Formula
- Functional Food & Beverages
- Food Supplements
- Others (Clinical Nutrition & Pharmaceuticals)
By Type
By Concentration
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- BASF SE
- Chr.Hansen Holding A/S
- DuPont de Nemours, Inc.
- Nestle S.A
- Inbiose NV
- Biosynth AG
- Abbott Laboratories
- Royal FrieslandCampina N.V.
- Dextra Laboratories Ltd (ICE S.p.A)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Human Milk Oligosaccharides Market, by Application
1.4.2 North America Human Milk Oligosaccharides Market, by Type
1.4.3 North America Human Milk Oligosaccharides Market, by Concentration
1.4.4 North America Human Milk Oligosaccharides Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4 Porter Five Forces Analysis
Chapter 5. North America Human Milk Oligosaccharides Market, by Application
5.1 North America Infant Formula Market, by Country
5.2 North America Functional Food & Beverages Market, by Country
5.3 North America Food Supplements Market, by Country
5.4 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
Chapter 6. North America Human Milk Oligosaccharides Market, by Type
6.1 North America 2'FL Market, by Country
6.2 North America 3'FL Market, by Country
6.3 North America 3'SL Market, by Country
6.4 North America 6'SL Market, by Country
Chapter 7. North America Human Milk Oligosaccharides Market, by Concentration
7.1 North America Neutral Market, by Country
7.2 North America Acidic Market, by Country
Chapter 8. North America Human Milk Oligosaccharides Market, by Country
8.1 US Human Milk Oligosaccharides Market
8.1.1 US Human Milk Oligosaccharides Market, by Application
8.1.2 US Human Milk Oligosaccharides Market, by Type
8.1.3 US Human Milk Oligosaccharides Market, by Concentration
8.2 Canada Human Milk Oligosaccharides Market
8.2.1 Canada Human Milk Oligosaccharides Market, by Application
8.2.2 Canada Human Milk Oligosaccharides Market, by Type
8.2.3 Canada Human Milk Oligosaccharides Market, by Concentration
8.3 Mexico Human Milk Oligosaccharides Market
8.3.1 Mexico Human Milk Oligosaccharides Market, by Application
8.3.2 Mexico Human Milk Oligosaccharides Market, by Type
8.3.3 Mexico Human Milk Oligosaccharides Market, by Concentration
8.4 Rest of North America Human Milk Oligosaccharides Market
8.4.1 Rest of North America Human Milk Oligosaccharides Market, by Application
8.4.2 Rest of North America Human Milk Oligosaccharides Market, by Type
8.4.3 Rest of North America Human Milk Oligosaccharides Market, by Concentration
Chapter 9. Company Profiles
9.1 Inbiose NV
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Biosynth AG
9.2.1 Company Overview
9.2.2 SWOT Analysis
9.3 Dextra Laboratories Ltd (ICE S.p.A)
9.3.1 Company Overview
9.4 Koninklijke DSM N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Trials and Approvals:
9.4.5.2 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 BASF SE
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.1 SWOT Analysis
9.6 Chr. Hansen Holding A/S
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segment & Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Trials and Approvals:
9.6.5.2 Acquisition and Mergers:
9.7 DuPont de Nemours, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Nestle S.A
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Abbott Laboratories
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.9.6 SWOT Analysis
9.10. Royal FrieslandCampina N.V.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Trials and Approvals:
9.10.6 SWOT Analysis
TABLE 1 North America Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 2 North America Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 3 Partnerships, Collaborations and Agreements– Human Milk Oligosaccharides Market
TABLE 4 Product Launches And Product Expansions– Human Milk Oligosaccharides Market
TABLE 5 Acquisition and Mergers– Human Milk Oligosaccharides Market
TABLE 6 Trials and Approvals- Human Milk Oligosaccharides Market
TABLE 7 North America Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 8 North America Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 9 North America Infant Formula Market, by Country, 2019 - 2022, USD Thousand
TABLE 10 North America Infant Formula Market, by Country, 2023 - 2030, USD Thousand
TABLE 11 North America Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
TABLE 12 North America Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
TABLE 13 North America Food Supplements Market, by Country, 2019 - 2022, USD Thousand
TABLE 14 North America Food Supplements Market, by Country, 2023 - 2030, USD Thousand
TABLE 15 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
TABLE 16 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
TABLE 17 North America Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 18 North America Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 19 North America 2'FL Market, by Country, 2019 - 2022, USD Thousand
TABLE 20 North America 2'FL Market, by Country, 2023 - 2030, USD Thousand
TABLE 21 North America 3'FL Market, by Country, 2019 - 2022, USD Thousand
TABLE 22 North America 3'FL Market, by Country, 2023 - 2030, USD Thousand
TABLE 23 North America 3'SL Market, by Country, 2019 - 2022, USD Thousand
TABLE 24 North America 3'SL Market, by Country, 2023 - 2030, USD Thousand
TABLE 25 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
TABLE 26 North America 6'SL Market, by Country, 2023 - 2030, USD Thousand
TABLE 27 North America Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 28 North America Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 29 North America Neutral Market, by Country, 2019 - 2022, USD Thousand
TABLE 30 North America Neutral Market, by Country, 2023 - 2030, USD Thousand
TABLE 31 North America Acidic Market, by Country, 2019 - 2022, USD Thousand
TABLE 32 North America Acidic Market, by Country, 2023 - 2030, USD Thousand
TABLE 33 North America Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
TABLE 34 North America Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
TABLE 35 US Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 36 US Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 37 US Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 38 US Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 39 US Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 40 US Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 41 US Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 42 US Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 43 Canada Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 44 Canada Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 45 Canada Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 46 Canada Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 47 Canada Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 48 Canada Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 49 Canada Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 50 Canada Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 51 Mexico Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 52 Mexico Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 53 Mexico Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 54 Mexico Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 55 Mexico Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 56 Mexico Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 57 Mexico Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 58 Mexico Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 59 Rest of North America Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 60 Rest of North America Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 61 Rest of North America Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 62 Rest of North America Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 63 Rest of North America Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 64 Rest of North America Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 65 Rest of North America Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 66 Rest of North America Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 67 Key Information – Inbiose NV
TABLE 68 Key Information – Biosynth AG
TABLE 69 Key Information – Dextra Laboratories Ltd
TABLE 70 Key Information – Koninklijke DSM N.V.
TABLE 71 Key Information – BASF SE
TABLE 72 Key Information – Chr. Hansen Holding A/S
TABLE 73 Key Information –DuPont de Nemours, Inc.
TABLE 74 Key Information – Nestle S.A
TABLE 75 Key Information – Abbott Laboratories
TABLE 76 Key Information – Royal FrieslandCampina N.V.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Human Milk Oligosaccharides Market, 2019 - 2030, USD Thousand
FIG 3 Key Factors Impacting the Human Milk Oligosaccharides Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Porter’s Five Forces Analysis – Human Milk Oligosaccharides Market
FIG 7 North America Human Milk Oligosaccharides Market, Share by Application, 2022
FIG 8 North America Human Milk Oligosaccharides Market, Share by Application, 2030
FIG 9 North America Human Milk Oligosaccharides Market, by Application, 2019 - 2030, USD Thousand
FIG 10 North America Human Milk Oligosaccharides Market, Share by Type, 2022
FIG 11 North America Human Milk Oligosaccharides Market, Share by Type, 2030
FIG 12 North America Human Milk Oligosaccharides Market, by Type, 2019 - 2030, USD Thousand
FIG 13 North America Human Milk Oligosaccharides Market, Share by Concentration, 2022
FIG 14 North America Human Milk Oligosaccharides Market, Share by Concentration, 2030
FIG 15 North America Human Milk Oligosaccharides Market, by Concentration, 2019 - 2030, USD Thousand
FIG 16 North America Human Milk Oligosaccharides Market, Share by Country, 2022
FIG 17 North America Human Milk Oligosaccharides Market, Share by Country, 2030
FIG 18 North America Human Milk Oligosaccharides Market, by Country, 2019 - 2030, USD Thousand
FIG 19 SWOT Analysis: Inbiose NV
FIG 20 SWOT Analysis: Biosynth AG
FIG 21 SWOT Analysis: Koninklijke DSM N.V.
FIG 22 Recent strategies and developments: BASF SE
FIG 23 SWOT Analysis: BASF SE
FIG 24 SWOT Analysis: DuPont de Nemours, Inc.
FIG 25 SWOT Analysis: Nestle S.A
FIG 26 SWOT Analysis: Abbott Laboratories
FIG 27 Recent strategies and developments: Royal FrieslandCampina N.V.
FIG 28 SWOT Analysis: Royal FrieslandCampina N.V.